Evidence map›Paper›PMID 37809097›Full record

SynthesisFrontiers in immunology2023

PheWAS and cross-disorder analysis reveal genetic architecture, pleiotropic loci and phenotypic correlations across 11 autoimmune disorders.

Apostolia Topaloudi, Pritesh Jain, Melanie B Martinez, Josephine K Bryant, Grace Reynolds, Zoi Zagoriti, George Lagoumintzis, Eleni Zamba-Papanicolaou, John Tzartos, Konstantinos Poulas and 5 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 3 countries.

Apostolia TopaloudiDepartment of Biological Sciences, Purdue University, West Lafayette, IN, United States.
Pritesh JainDepartment of Biological Sciences, Purdue University, West Lafayette, IN, United States.
Melanie B MartinezDepartment of Biological Sciences, Purdue University, West Lafayette, IN, United States.
Josephine K BryantDepartment of Biological Sciences, Purdue University, West Lafayette, IN, United States.
Grace ReynoldsDepartment of Biological Sciences, Purdue University, West Lafayette, IN, United States.
Zoi ZagoritiDepartment of Pharmacy, University of Patras, Rio, Greece.
George LagoumintzisDepartment of Pharmacy, University of Patras, Rio, Greece.
Eleni Zamba-PapanicolaouDepartment of Neuroepidemiology and Centre for Neuromuscular Disorders, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
John TzartosB' Neurology Department, School of Medicine, National & Kapodistrian University of Athens, "Attikon" University Hospital., Athens, Greece.
Konstantinos PoulasDepartment of Pharmacy, University of Patras, Rio, Greece.
Kleopas A KleopaDepartment of Neuroscience and Centre for Neuromuscular Disorders, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Socrates TzartosDepartment of Pharmacy, University of Patras, Rio, Greece.
Marianthi GeorgitsiDepartment of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, Alexandroupoli, Greece.
Petros DrineasDepartment of Computer Science, Purdue University, West Lafayette, IN, United States.
Peristera PaschouDepartment of Biological Sciences, Purdue University, West Lafayette, IN, United States.
Purdue University West Lafayette · USUniversity of Patras · GRCyprus Institute of Neurology and Genetics · CYDemocritus University of Thrace · GRLafayette School Corporation · USNational and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Autoimmune disorders (ADs) are a group of about 80 disorders that occur when self-attacking autoantibodies are produced due to failure in the self-tolerance mechanisms. ADs are polygenic disorders and associations with genes both in the human leukocyte antigen (HLA) region and outside of it have been described. Previous studies have shown that they are highly comorbid with shared genetic risk factors, while epidemiological studies revealed associations between various lifestyle and health-related phenotypes and ADs. Methods: Here, for the first time, we performed a comparative polygenic risk score (PRS) - Phenome Wide Association Study (PheWAS) for 11 different ADs (Juvenile Idiopathic Arthritis, Primary Sclerosing Cholangitis, Celiac Disease, Multiple Sclerosis, Rheumatoid Arthritis, Psoriasis, Myasthenia Gravis, Type 1 Diabetes, Systemic Lupus Erythematosus, Vitiligo Late Onset, Vitiligo Early Onset) and 3,254 phenotypes available in the UK Biobank that include a wide range of socio-demographic, lifestyle and health-related outcomes. Additionally, we investigated the genetic relationships of the studied ADs, calculating their genetic correlation and conducting cross-disorder GWAS meta-analyses for the observed AD clusters. Results: In total, we identified 508 phenotypes significantly associated with at least one AD PRS. 272 phenotypes were significantly associated after excluding variants in the HLA region from the PRS estimation. Through genetic correlation and genetic factor analyses, we identified four genetic factors that run across studied ADs. Cross-trait meta-analyses within each factor revealed pleiotropic genome-wide significant loci. Discussion: Overall, our study confirms the association of different factors with genetic susceptibility for ADs and reveals novel observations that need to be further explored.

Indexed as

Autoimmune DiseasesDiabetes Mellitus, Type 1VitiligoHLA AntigensHumansPhenotypePolymorphism, Single NucleotideHLA Antigensautoimmune disorderscross-disorderGWASmeta-analysisPheWASPRS

Identifiers

PMID37809097
PMCPMC10552152
OpenAlexW4386916327

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.